Stay updated on TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the TITAN-TCC clinical trial record, including its study design, eligibility criteria, treatment plan, outcomes, and locations, instead of a 403 error.
    Difference
    67%
    Check dated 2026-11-08T14:45:14.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-11-01T15:57:36.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces updates and FAQs about a terminology transition, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T15:16:11.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T15:04:30.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T15:11:58.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Displays a 403 Forbidden error page instead of the study record content, replacing detailed study information and navigation. The page chrome includes a basic header and a Home button, with a revision note indicating the version update.
    Difference
    19%
    Check dated 2026-09-20T11:22:15.000Z thumbnail image

Stay in the know with updates to TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.